The COVID-19 vaccine’s mRNA technology is now being used in a ground-breaking personalized pancreatic cancer vaccine. This Phase II trial, a collaboration between Memorial Sloan Kettering Cancer Center, Genentech, and BioNTech, could radically change cancer treatment. The custom-made vaccine stimulates the immune system to recognize and attack a person’s individual cancer cells, possibly improving survival rates. Though focused on pancreatic cancer, mRNA vaccines have potential for other types of deadly cancer. This ongoing progress with mRNA technology could lead to a major change in cancer therapy, transitioning from a terminal disease to a manageable condition.

Full article here: https://lawsuithelpdesk.com/revolutionizing-cancer-treatment-the-dawn-of-personalized-mrna-vaccines-2/